Professional Documents
Culture Documents
UK-based Astra Zeneca PLC and Swiss-based Roche Group are two of the largest pharmaceutical
companies in Europe. The following information was provided in each company’s 2016 annual report.
ASTRA-ZENECA
Annual Report 2016
Turnover* Net Operating Assets
Geographic Areas Employees
($ million) ($ million)
United Kingdom $3,964 $3,101 10,700
Continental Europe $6,674 $4,805 22,600
The Americas $10,464 $1,004 17,800
Asia, Africa and Australia $1,742 $958 6,400
*Turnover = Sales
ROCHE GROUP
Annual Report 2016
Sales Segment Areas
Geographical Information Headcount
(CHF million) (CHF million)
Switzerland 532 5,272 8,569
European Union 9,067 11,872
Rest of Europe 1,439 494 23,982*
North America 11,297 16,194 17,988
Latin America 2,393 1,493 5,816
Japan 2,243 4,229 6,381
Rest of Asia 1,805 679 5,169
Africa, Australia and Oceania 949 273 1,754
*Roche does not split Headcount in Europe other than Switzerland into European Union and Rest of Europe
Required:
Use the Unite Nations formula to determine which of these two companies is more multinational.
2. Access the financial statements from the most recent annual report of two foreign companies
located in the same country to complete this assignment.
a. Determine the accounting principles (GAAP) the two foreign companies use to prepare financial
statements.
b. Determine whether the two foreign companies provide a set of financial statements that includes
the same components (e.g., consolidated balance sheet, consolidate income statement,
consolidated cash flows statement).
c. List any format differences in the companies’ income statement.
d. List any format differences in the companies’ balance sheets.
e. Note any terminology differences that exist between the two companies’ income statements and
balance sheets.
f. Assess whether the scope and content of the information provided in the notes to the financial
statements is similar between the two companies.
The entire inventory of Product Z that was on hand at December 31, year 1, was completed
in Year 2 at a cost of $1,800 and sold at a price of $17,150.